A review of 16 randomized trials
The researchers pooled 16 randomized controlled trials of exercise in patients with lung cancer. Their literature search covered four scientific databases through April 2026. They combined a conventional meta-analysis, a network comparison of exercise types and an analysis of the relationship between exercise volume and depressive symptoms.
The dossier provides access only to the PubMed abstract, not the full text. This abstract does not specify intervention durations, details of the comparator groups, cancer stages or treatments received. This missing information limits the ability to determine which patients the findings apply to best.
An average benefit, but variable results
The overall analysis reports a reduction in depressive symptoms, with a standardized mean difference of −0.63 and a 95% confidence interval ranging from −0.88 to −0.38. This measure allows assessments using different scales to be pooled. It represents neither a 63% reduction in symptoms nor a proportion of patients cured.
Heterogeneity between trials is substantial, with an I² of 72%. The average result therefore masks differences between studies. Without the scales used and their thresholds for clinical improvement, the abstract does not allow this effect to be translated into a tangible benefit for an individual patient.
Aerobic exercise ranks first, with low confidence
In the network comparison, aerobic exercise has the most favorable effect estimate. However, the authors rate confidence in this finding as low. This ranking is therefore not enough to establish its superiority over other exercise types.
Interventions most closely aligned with American College of Sports Medicine recommendations also show greater improvement. This alignment describes the programs studied: it should not be confused with individual participants’ adherence.
A dose–response relationship, not a prescription
The authors report a nonlinear relationship between weekly exercise volume and depressive symptoms. However, the threshold derived from this modeling is not a validated minimum dose for every patient.
This review supports the potential value of exercise for depressive symptoms in lung cancer. It demonstrates neither a cure for depression, nor an effect on the cancer itself, nor the possibility of replacing psychological or medical care.
Limitations to keep in mind
PubMed abstract only; full text not consulted. Substantial heterogeneity in results and low confidence regarding aerobic exercise. Durations, detailed comparators, adverse events, funding and conflicts of interest were not verified in the dossier.
What we can take away
The signal favors exercise, but the available data do not allow an optimal exercise type or volume to be chosen with confidence for each patient.
Sources and provenance
- Impact of exercise dose on depression and mood in patients with lung cancer: a systematic review with pairwise, network, and dose-response meta-analyses.
Source date: 2026-11-21.
Journal Article, Systematic Review, Network Meta-Analysis, Review · Résumé PubMed uniquement, texte intégral non consulté


